HEXO (HEXO) Stock Buy Rating Maintained at Oppenheimer; The PT is $7; HUT 8 MINING (HUTMF) Shorts Raised By 15.38%

HUT 8 MINING CORP (OTCMKTS:HUTMF) had an increase of 15.38% in short interest. HUTMF’s SI was 4,500 shares in March as released by FINRA. Its up 15.38% from 3,900 shares previously. With 12,900 avg volume, 0 days are for HUT 8 MINING CORP (OTCMKTS:HUTMF)’s short sellers to cover HUTMF’s short positions. It closed at $0.9097 lastly. It is up 0.00% since March 15, 2018 and is . It has underperformed by 4.37% the S&P500.

HEXO Corp (HEXO) had its stock rating noted as Buy by analysts at Oppenheimer. Oppenheimer currently has a $7 TP on the $1.27 billion market cap company or 14.94% upside potential. This was revealed to investors in analysts note on Friday morning.

The stock decreased 0.16% or $0.01 during the last trading session, reaching $6.09. About 3.77M shares traded or 61.58% up from the average. HEXO Corp. (HEXO) has risen 91.88% since March 15, 2018 and is uptrending. It has outperformed by 87.51% the S&P500.

More notable recent HEXO Corp. (NYSEAMERICAN:HEXO) news were published by: Profitconfidential.com which released: “If You Had Invested $1,000 in HEXO Stock Two Years Ago, Here’s How Much You Would Have Made – Profit Confidential” on March 12, 2019, also 247Wallst.com with their article: “Marijuana Grower Hexo Spends to Grow – 24/7 Wall St.” published on March 14, 2019, Schaeffersresearch.com published: “Drug Stock More than Doubles After FDA Nod – Schaeffers Research” on March 13, 2019. More interesting news about HEXO Corp. (NYSEAMERICAN:HEXO) were released by: Profitconfidential.com and their article: “Marijuana News Today: U.S. Marijuana Legalization Expands, HEXO Stock Climbs – Profit Confidential” published on March 14, 2019 as well as Profitconfidential.com‘s news article titled: “Marijuana News Today: Pot Spurs Job Growth, Helps Speed Along U.S. Legalization – Profit Confidential” with publication date: March 15, 2019.

HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company has market cap of $1.27 billion. The firm offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It currently has negative earnings. It provides its products under the HEXO and Hydropothecary brand names.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.